128 results
P
patients with angina pectoris (AP)
I/C
Kuanxiong Aerosol (KA), nitrates
O
clinical efficacy and safety, 3-min and 5-min angina remission rates, incidence of adverse reactions, endothelin (ET), c-reactive protein (CRP), electrocardiogram efficacy, nitric oxide (NO)
P
individuals who had never experienced the outcome event before the baseline assessment
I/C
breaking up consecutive sedentary bouts >30 to 60 min and substituting them with brief bouts of physical activity, prolonged sedentary behavior patterns
O
adverse health outcomes, noncommunicable diseases, all-cause mortality
P
athletes
I/C
off-training sedentary behavior and physical activity levels, general population
O
sedentary behavior (+79 min/day)
P
patients with eGFR <60 ml/min/1.73 m
I/C
SGLT2 inhibitors, placebo
O
safety outcomes
P
patients with severe mitral regurgitation (MR)
I/C
PASCAL mitral valve repair system
O
reduction in MR grade, operative time, increase in 6-min walk test
P
patients with chronic coronary syndromes
I/C
incremental unit of stress MBF (mL/g/min) or low MBF versus high MBF, stress MBF data by unit increments
O
occurrence of MACE during follow-up, summarized as time-to-event hazard ratios (HRs) and 95% confidence intervals (CIs)
P
COPD patients
I/C
dietary nitrate-rich beetroot juice, placebo
O
systolic blood pressure, diastolic blood pressure, heart rate, 6-min walk test, cycling ergometry endurance time, maximum rate of oxygen consumption (VO2)
P
immigrants from conflict-zone countries, native-origin women
I/C
native-origin women
O
perinatal and neonatal outcomes, small for gestational age, 5-min Apgar score <7, stillbirth, perinatal mortality, cesarean section, emergency C-S, instrumental delivery, preeclampsia, gestational diabetes
P
patients with type 2 diabetes
I/C
derivation cohort, risk assessment model, external validation cohorts
O
occurrence of ESRD defined as eGFR<15 ml min
P
Asian population
I/C
O
CKD defined as eGFR <60 mL/min/1.73 m